What is Nektar Therapeutics's total revenue?

Nektar Therapeutics (NKTR) reported total revenue of $10.86M in Q1 2026.

How has Nektar Therapeutics's total revenue changed year-over-year?

Nektar Therapeutics's total revenue increased by 3.8% year-over-year, from $10.46M to $10.86M.

What is the long-term trend for Nektar Therapeutics's total revenue?

Over 4 years (2021 to 2025), Nektar Therapeutics's total revenue has grown at a -14.2% compound annual growth rate (CAGR), from $101.91M to $55.23M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Nektar Therapeutics NKTR Total Revenue

Total Revenue at other companies

AmgenAMGN

$8.62B+5.8%

Regeneron PharmaceuticalsREGN

$3.61B+19.0%

ImmunityBio, Inc.IBRX

$44.21M+168%

ImmunomeIMNM

$0-100%

Iovance Biotherapeutics, Inc.IOVA

$71.43M+44.8%

IncyteINCY

$1.27B+20.9%

Segments

By geography

See full

Non Us$55.23M-43.1%

By product

See full

Non Cash Royalty Revenue Related To Sale Of Future Royalties$10.9M+3.8%

Other financials

Income statement

See full

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Reported directly by Nektar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's total revenue?: Nektar Therapeutics (NKTR) reported total revenue of $10.86M in Q1 2026.
How has Nektar Therapeutics's total revenue changed year-over-year?: Nektar Therapeutics's total revenue increased by 3.8% year-over-year, from $10.46M to $10.86M.
What is the long-term trend for Nektar Therapeutics's total revenue?: Over 4 years (2021 to 2025), Nektar Therapeutics's total revenue has grown at a -14.2% compound annual growth rate (CAGR), from $101.91M to $55.23M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.